Answer
Current NHS programmes target eligible very premature infants and children with particular heart, lung or immune-system risks. Hospital specialists determine eligibility, and product availability may affect which RSV antibody is used.
Sources for this answer
- UK GovernmentUK Government · Reputable Web
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.